BIA Events

SynbiTECH is the UK’s leading international forum for people engaged in engineering biology business, investment, policymaking, science and research. Running for the sixth time, this major UK synthetic biology business conference attracted more than 400 delegates and speakers, bringing together the best and brightest minds in synthetic biology, sustainability and business innovation

Join FTI Consulting’s Life Sciences Spotlight Webcast where our team of tax experts will discuss the 2025 Autumn Budget update, recent tax changes and explore the implications for Life Sciences companies.

During this webinar, we will discuss the following key points: How cytokine-pathway editing (e.g., IFNγ sensing) can be leveraged to uncouple efficacy from attrition. Why engineering choices must be contextualized by costimulatory domain, as CD28 and 4-1BB parse cytokine cues differently. How subset-aware strategies are essential to optimize persistence and function for CAR-T cells.

Interferon-gamma (IFNγ) is a double-edged cytokine for adoptive cell therapy in solid tumors. While IFNγ is required for CAR-T cell efficacy against these cancers, its direct uptake by CAR-T cells with a CD28 costimulatory domain can restrict their expansion, persistence, and overall effectiveness. To address this challenge, new strategies are being developed to re-engineer CAR-T cells, allowing them to overcome their limitations and produce more durable antitumor responses.

Next Generation Particle Analytics: Label-free Insights at the Single-Particle Level

What if...there were an apprenticeship for scientific imagination? Are you a bold, creative scientist ready to spend a summer learning how world-changing biotech companies are built from the ground up?

Showcasing Cambridge & London life science, biotech, deeptech & techbio ventures, offering investors early insight, and emerging innovation.

Do you have a cancer detection or diagnostic idea? Are you interested in participating in or informing the development of innovative approaches through collaborative R&D? Then join us for one of three cross-disciplinary collaborative sandpits focused on driving the early detection and diagnosis of cancer.

The leadership development programme for leaders in the Life Sciences

Do you have an idea that could help reduce the diagnosis time for endometriosis from over seven years to one? We are looking for businesses with innovative concepts or ideas that have the potential to evolve into clinically credible, commercially viable and system-ready solutions for accelerating endometriosis diagnosis and treatment.